Non-Standardized Chemical Allergen [EPC]

Non-Standardized Chemical Allergen [EPC] was reported 77387 times

Drugs of the Non-Standardized Chemical Allergen [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 628 0.5913
1 VAGINAL FLATULENCE 155 0.5116
2 INSPIRATORY CAPACITY DECREASED 88 0.3177
3 SLEEP DISORDER THERAPY 61 0.3081
4 APPENDICOLITH 89 0.2300
5 ANALGESIC THERAPY 61 0.1900
6 DRUG THERAPY 61 0.1799
7 MATERNAL EXPOSURE DURING DELIVERY 157 0.1584
8 TOXIC ANTERIOR SEGMENT SYNDROME 170 0.1558
9 ORAL HERPES 2540 0.1300
10 INFUSION SITE DISCHARGE 226 0.1288
11 HERPES SIMPLEX 738 0.1134
12 METHAEMOGLOBINAEMIA 247 0.1066
13 FEMALE GENITAL TRACT FISTULA 174 0.1018
14 INFUSION SITE MASS 100 0.0920
15 SCLERAL HYPERAEMIA 61 0.0896
16 INFUSION SITE URTICARIA 59 0.0881
17 APPLICATION SITE SCAR 109 0.0871
18 INFUSION SITE BRUISING 185 0.0856
19 INFUSION SITE PRURITUS 260 0.0823
20 CHRONIC SINUSITIS 301 0.0801
21 LIP HAEMORRHAGE 100 0.0784
22 MULTIPLE DRUG THERAPY 59 0.0782
23 APPLICATION SITE SCAB 169 0.0782
24 INFUSION SITE HAEMORRHAGE 250 0.0759
25 ENDOCRINE OPHTHALMOPATHY 65 0.0749
26 RADICULOPATHY 197 0.0747
27 MACULAR DEGENERATION 880 0.0736
28 PERIORBITAL PAIN 62 0.0732
29 SEDATION COMPLICATION 182 0.0713
30 APPLICATION SITE PARAESTHESIA 90 0.0690
31 INFUSION SITE RASH 89 0.0648
32 INFUSION SITE SWELLING 392 0.0622
33 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 65 0.0612
34 DRUG ADMINISTRATION ERROR 1848 0.0602
35 INFUSION SITE DISCOMFORT 62 0.0598
36 PROCTITIS 166 0.0592
37 LIP PAIN 162 0.0564
38 ANAESTHETIC COMPLICATION 147 0.0547
39 EYELID PAIN 107 0.0526
40 INFUSION SITE WARMTH 63 0.0514
41 NEPHROGENIC ANAEMIA 227 0.0490
42 KOUNIS SYNDROME 110 0.0484
43 HYPERPARATHYROIDISM SECONDARY 118 0.0470
44 HYPERPHOSPHATAEMIA 101 0.0469
45 INFUSION SITE ERYTHEMA 390 0.0462
46 DEVICE INFUSION ISSUE 114 0.0459
47 INFUSION SITE IRRITATION 59 0.0459
48 CREATININE RENAL CLEARANCE DECREASED 178 0.0444
49 INFUSION SITE PAIN 571 0.0443
50 INCORRECT DRUG ADMINISTRATION RATE 187 0.0439
51 FOREIGN BODY SENSATION IN EYES 279 0.0437
52 APPLICATION SITE SWELLING 214 0.0429
53 INFUSION SITE EXTRAVASATION 258 0.0414
54 LIP EXFOLIATION 53 0.0398
55 MULTIPLE ALLERGIES 312 0.0398
56 HYPERTHERMIA MALIGNANT 57 0.0383
57 LIP BLISTER 104 0.0382
58 VASOPLEGIA SYNDROME 61 0.0372
59 LIP DISORDER 69 0.0364
60 PRODUCT CONTAINER ISSUE 311 0.0362
61 APPLICATION SITE HAEMORRHAGE 98 0.0358
62 BLOOD PHOSPHORUS INCREASED 97 0.0355
63 CORNEAL OEDEMA 77 0.0343
64 INSURANCE ISSUE 525 0.0343
65 INFUSION SITE REACTION 98 0.0328
66 INCORRECT PRODUCT ADMINISTRATION DURATION 696 0.0321
67 SEASONAL ALLERGY 447 0.0315
68 PULSELESS ELECTRICAL ACTIVITY 126 0.0301
69 INCORRECT DRUG ADMINISTRATION DURATION 844 0.0300
70 CHEILITIS 159 0.0294
71 CHAPPED LIPS 120 0.0276
72 PARAESTHESIA ORAL 394 0.0273
73 APPLICATION SITE PAIN 580 0.0263
74 DERMATITIS CONTACT 300 0.0263
75 ABNORMAL SENSATION IN EYE 113 0.0263
76 DEAFNESS NEUROSENSORY 86 0.0261
77 REBOUND ACID HYPERSECRETION 77 0.0254
78 INSTILLATION SITE PAIN 63 0.0254
79 EYE DISCHARGE 262 0.0252
80 VENTRICULAR FIBRILLATION 279 0.0251
81 OBSTRUCTION 100 0.0250
82 EYE PAIN 1372 0.0243
83 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 80 0.0241
84 RESPIRATORY TRACT INFECTION VIRAL 55 0.0236
85 OCULAR DISCOMFORT 264 0.0235
86 IRON DEFICIENCY 104 0.0231
87 STRESS CARDIOMYOPATHY 130 0.0223
88 EYE IRRITATION 1279 0.0222
89 EYELID IRRITATION 55 0.0219
90 APPLICATION SITE DISCOLOURATION 88 0.0216
91 LUNG OPACITY 57 0.0216
92 VENTRICULAR TACHYCARDIA 353 0.0214
93 POOR VENOUS ACCESS 220 0.0212
94 END STAGE RENAL DISEASE 387 0.0212
95 APPLICATION SITE IRRITATION 264 0.0212
96 PARAPLEGIA 61 0.0211
97 EYELID MARGIN CRUSTING 61 0.0211
98 LIP SWELLING 700 0.0210
99 BLOOD CALCIUM DECREASED 232 0.0206
100 ORAL CANDIDIASIS 270 0.0205
101 PULSE ABSENT 97 0.0204
102 APPLICATION SITE DRYNESS 69 0.0203
103 EAR INFECTION 540 0.0203
104 ANAPHYLACTIC SHOCK 522 0.0202
105 SINUSITIS 2060 0.0201
106 RESPIRATORY TRACT INFECTION 523 0.0201
107 EYE OPERATION 91 0.0197
108 APPLICATION SITE REACTION 137 0.0195
109 RHINOVIRUS INFECTION 74 0.0190
110 OTITIS MEDIA 62 0.0187
111 PRODUCT DISTRIBUTION ISSUE 172 0.0185
112 HORDEOLUM 80 0.0185
113 PHOTOPHOBIA 346 0.0184
114 HYPOPHOSPHATAEMIA 134 0.0181
115 GENERALISED TONIC-CLONIC SEIZURE 298 0.0180
116 STATUS EPILEPTICUS 203 0.0180
117 TYPE I HYPERSENSITIVITY 63 0.0179
118 SKIN LACERATION 194 0.0178
119 UPPER RESPIRATORY TRACT INFECTION 824 0.0178
120 AORTIC STENOSIS 62 0.0178
121 ERYTHEMA OF EYELID 96 0.0177
122 RENAL FUNCTION TEST ABNORMAL 82 0.0176
123 EYE INFECTION 198 0.0175
124 VENTRICULAR HYPOKINESIA 56 0.0174
125 VAGINAL DISCHARGE 175 0.0173
126 SKIN ABRASION 81 0.0171
127 APPLICATION SITE VESICLES 111 0.0171
128 PROCTALGIA 110 0.0171
129 MYASTHENIA GRAVIS 138 0.0171
130 CARDIOGENIC SHOCK 245 0.0171
131 TENDERNESS 177 0.0170
132 BUNDLE BRANCH BLOCK LEFT 72 0.0170
133 BLOOD URIC ACID INCREASED 97 0.0168
134 VASCULAR DEVICE INFECTION 76 0.0167
135 SKIN INFECTION 186 0.0166
136 APNOEA 129 0.0166
137 LIP DRY 149 0.0164
138 ARTHRITIS INFECTIVE 76 0.0164
139 HAEMODYNAMIC INSTABILITY 124 0.0163
140 ASTHENOPIA 89 0.0162
141 STREPTOCOCCAL INFECTION 89 0.0160
142 PRODUCT COMPLAINT 402 0.0158
143 PRODUCT ADHESION ISSUE 564 0.0158
144 ANAPHYLACTIC REACTION 855 0.0155
145 GASTROENTERITIS VIRAL 279 0.0154
146 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 79 0.0154
147 ANHEDONIA 405 0.0154
148 SPINAL OSTEOARTHRITIS 135 0.0154
149 ATELECTASIS 148 0.0153
150 RESPIRATORY ACIDOSIS 60 0.0152
151 VENTRICULAR ARRHYTHMIA 55 0.0150
152 HYPOAESTHESIA ORAL 225 0.0149
153 THERAPEUTIC PRODUCT EFFECT DELAYED 68 0.0149
154 ARTHRITIS BACTERIAL 61 0.0148
155 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 75 0.0148
156 SINUS TACHYCARDIA 210 0.0148
157 RENAL INJURY 437 0.0147
158 ORAL DISCOMFORT 202 0.0145
159 PARANASAL SINUS DISCOMFORT 55 0.0145
160 MULTI-ORGAN FAILURE 250 0.0144
161 FACIAL PAIN 129 0.0144
162 APPLICATION SITE BURN 71 0.0144
163 FEAR 383 0.0142
164 SPINAL CORD COMPRESSION 55 0.0141
165 PHARYNGITIS STREPTOCOCCAL 152 0.0140
166 VITREOUS FLOATERS 138 0.0140
167 BRONCHIECTASIS 94 0.0139
168 APPENDICITIS 130 0.0139
169 SCAR 237 0.0138
170 VENTRICULAR EXTRASYSTOLES 142 0.0137
171 CATARACT 814 0.0137
172 PROCEDURAL PAIN 379 0.0136
173 MENINGITIS ASEPTIC 61 0.0136
174 TOOTH INFECTION 179 0.0136
175 INTERVERTEBRAL DISC DEGENERATION 125 0.0135
176 ENDOPHTHALMITIS 81 0.0135
177 INFUSION RELATED REACTION 893 0.0135
178 PRODUCT ADMINISTRATION INTERRUPTED 105 0.0134
179 HYPOXIA 471 0.0134
180 ORTHOSTATIC HYPOTENSION 232 0.0133
181 APPLICATION SITE ERYTHEMA 349 0.0133
182 RHINITIS ALLERGIC 59 0.0132
183 HYPERLIPIDAEMIA 158 0.0132
184 SWELLING OF EYELID 83 0.0132
185 GASTROINTESTINAL INFECTION 118 0.0132
186 NYSTAGMUS 69 0.0130
187 RESPIRATORY DEPRESSION 159 0.0130
188 OCULAR HYPERAEMIA 615 0.0129
189 NEURALGIA 315 0.0129
190 LACRIMATION INCREASED 391 0.0129
191 SKIN WARM 75 0.0129
192 PRODUCT USE COMPLAINT 203 0.0129
193 DRY EYE 642 0.0128
194 PSEUDOMONAS INFECTION 110 0.0128
195 BREATH SOUNDS ABNORMAL 63 0.0128
196 BACTERIAL INFECTION 237 0.0127
197 DECUBITUS ULCER 103 0.0126
198 BRONCHITIS 934 0.0126
199 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 216 0.0126
200 UNRESPONSIVE TO STIMULI 324 0.0125
201 SINUS DISORDER 248 0.0125
202 GLUCOSE TOLERANCE IMPAIRED 74 0.0125
203 CARDIAC ARREST 1027 0.0124
204 RESPIRATORY SYNCYTIAL VIRUS INFECTION 108 0.0124
205 LIVE BIRTH 103 0.0123
206 SINUS BRADYCARDIA 119 0.0123
207 SCAB 140 0.0123
208 KIDNEY INFECTION 238 0.0121
209 BRAIN OEDEMA 153 0.0121
210 PERIPHERAL VASCULAR DISORDER 62 0.0120
211 TROPONIN INCREASED 91 0.0119
212 MOUTH SWELLING 69 0.0119
213 BRADYCARDIA 634 0.0119
214 PRODUCT ODOUR ABNORMAL 125 0.0119
215 VIRAL INFECTION 397 0.0119
216 FOOD POISONING 63 0.0118
217 PRE-EXISTING CONDITION IMPROVED 73 0.0117
218 POST PROCEDURAL INFECTION 95 0.0117
219 PHARYNGITIS 144 0.0116
220 HAEMORRHOIDS 226 0.0116
221 CHRONIC KIDNEY DISEASE 878 0.0115
222 MYDRIASIS 148 0.0115
223 EYE INFLAMMATION 110 0.0115
224 NEUROTOXICITY 201 0.0115
225 VARICOSE VEIN 59 0.0114
226 MENTAL STATUS CHANGES 317 0.0114
227 HYPERVOLAEMIA 56 0.0113
228 SENSORY LOSS 91 0.0113
229 CANDIDA INFECTION 190 0.0112
230 TOOTH ABSCESS 114 0.0112
231 WEIGHT FLUCTUATION 116 0.0111
232 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 98 0.0111
233 HYPERAESTHESIA 91 0.0111
234 MYOCLONUS 132 0.0111
235 RALES 64 0.0110
236 TORSADE DE POINTES 86 0.0110
237 LOCALISED INFECTION 262 0.0108
238 POST PROCEDURAL COMPLICATION 208 0.0108
239 BRONCHOSPASM 154 0.0108
240 EYELID PTOSIS 109 0.0107
241 RENAL CYST 85 0.0107
242 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 586 0.0107
243 CYSTITIS 340 0.0107
244 FOOD ALLERGY 82 0.0106
245 CONCUSSION 82 0.0106
246 DEPRESSED LEVEL OF CONSCIOUSNESS 418 0.0106
247 STAPHYLOCOCCAL INFECTION 348 0.0105
248 NORMAL NEWBORN 57 0.0105
249 BENIGN PROSTATIC HYPERPLASIA 54 0.0104
250 PROCEDURAL COMPLICATION 80 0.0104
251 CIRCULATORY COLLAPSE 177 0.0104
252 LEFT VENTRICULAR DYSFUNCTION 69 0.0103
253 HIATUS HERNIA 132 0.0102
254 URINARY TRACT INFECTION 1737 0.0102
255 ECONOMIC PROBLEM 154 0.0102
256 EAR PAIN 197 0.0101
257 ARTHROPOD BITE 75 0.0101
258 CELLULITIS 507 0.0101
259 MENINGITIS 67 0.0100
260 ACUTE RESPIRATORY FAILURE 193 0.0100
261 FREQUENT BOWEL MOVEMENTS 268 0.0099
262 RENAL TUBULAR NECROSIS 97 0.0099
263 SEDATION 258 0.0098
264 UPPER-AIRWAY COUGH SYNDROME 81 0.0098
265 GINGIVITIS 53 0.0098
266 RIB FRACTURE 202 0.0098
267 CONDITION AGGRAVATED 2979 0.0098
268 HYPERKERATOSIS 54 0.0098
269 NERVE COMPRESSION 90 0.0097
270 LIQUID PRODUCT PHYSICAL ISSUE 71 0.0097
271 ESCHERICHIA INFECTION 80 0.0097
272 HYPOTENSION 1930 0.0096
273 ORAL PAIN 214 0.0095
274 SCIATICA 152 0.0095
275 RENAL FAILURE 1266 0.0095
276 NERVE INJURY 106 0.0095
277 PRODUCTIVE COUGH 454 0.0095
278 SUPRAVENTRICULAR TACHYCARDIA 91 0.0095
279 RESPIRATORY TRACT CONGESTION 151 0.0095
280 RENAL FAILURE CHRONIC 73 0.0095
281 FIBROMYALGIA 230 0.0095
282 INJURY 665 0.0095
283 EXPIRED PRODUCT ADMINISTERED 314 0.0094
284 CLOSTRIDIUM DIFFICILE COLITIS 100 0.0094
285 CARDIOTOXICITY 84 0.0094
286 COVID-19 PNEUMONIA 111 0.0094
287 IMPAIRED GASTRIC EMPTYING 128 0.0094
288 SWELLING FACE 610 0.0094
289 THERAPY PARTIAL RESPONDER 146 0.0093
290 POSTOPERATIVE WOUND INFECTION 63 0.0093
291 IMPAIRED QUALITY OF LIFE 134 0.0093
292 IRON DEFICIENCY ANAEMIA 86 0.0093
293 ROTATOR CUFF SYNDROME 119 0.0093
294 ATRIOVENTRICULAR BLOCK COMPLETE 62 0.0093
295 LIGAMENT SPRAIN 91 0.0092
296 ECCHYMOSIS 63 0.0092
297 PNEUMONIA ASPIRATION 229 0.0092
298 DIPLOPIA 238 0.0092
299 VITAMIN D DEFICIENCY 89 0.0091
300 BLOOD CALCIUM INCREASED 80 0.0091
301 LYMPHOEDEMA 63 0.0091
302 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1641 0.0091
303 EXOSTOSIS 83 0.0091
304 DRUG INEFFECTIVE 11925 0.0090
305 COLITIS 343 0.0090
306 FEBRILE NEUTROPENIA 599 0.0090
307 LIMB INJURY 245 0.0090
308 MUSCLE STRAIN 78 0.0090
309 ANAL INCONTINENCE 81 0.0090
310 MUSCULOSKELETAL CHEST PAIN 139 0.0090
311 NECK PAIN 501 0.0090
312 WALKING AID USER 59 0.0089
313 ILLNESS 919 0.0089
314 TACHYPNOEA 121 0.0089
315 SINUS CONGESTION 120 0.0089
316 ORAL DISORDER 65 0.0089
317 SLEEP APNOEA SYNDROME 169 0.0088
318 MIOSIS 71 0.0088
319 INTENTIONAL DRUG MISUSE 184 0.0088
320 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 626 0.0088
321 FACIAL PARALYSIS 75 0.0088
322 CARPAL TUNNEL SYNDROME 123 0.0088
323 BRAIN FOG 137 0.0087
324 OSTEOMYELITIS 158 0.0087
325 SPINAL PAIN 102 0.0087
326 JOINT EFFUSION 60 0.0087
327 COVID-19 1524 0.0087
328 BLADDER DISORDER 86 0.0087
329 EYE PRURITUS 291 0.0087
330 EYE SWELLING 322 0.0086
331 TOXICITY TO VARIOUS AGENTS 1455 0.0086
332 FOOT FRACTURE 163 0.0086
333 THERMAL BURN 61 0.0086
334 DRUG LEVEL INCREASED 142 0.0086
335 DRUG EFFECT LESS THAN EXPECTED 127 0.0086
336 BLINDNESS TRANSIENT 63 0.0085
337 SMALL INTESTINAL OBSTRUCTION 105 0.0085
338 POST-TRAUMATIC STRESS DISORDER 57 0.0085
339 OSTEOPENIA 129 0.0085
340 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 443 0.0085
341 EYE MOVEMENT DISORDER 58 0.0085
342 PNEUMOTHORAX 134 0.0084
343 BLOOD ALBUMIN DECREASED 67 0.0084
344 PRODUCT QUALITY ISSUE 1146 0.0084
345 WRONG PRODUCT ADMINISTERED 57 0.0084
346 EYELID OEDEMA 98 0.0084
347 FLANK PAIN 79 0.0084
348 MALNUTRITION 94 0.0084
349 GLAUCOMA 161 0.0084
350 RECTAL HAEMORRHAGE 359 0.0083
351 TACHYCARDIA 742 0.0083
352 POOR QUALITY PRODUCT ADMINISTERED 88 0.0083
353 GRAND MAL CONVULSION 77 0.0083
354 HAND FRACTURE 59 0.0083
355 ARTERIOSCLEROSIS CORONARY ARTERY 55 0.0083
356 VISION BLURRED 1134 0.0083
357 MULTIPLE ORGAN DYSFUNCTION SYNDROME 233 0.0082
358 COGNITIVE DISORDER 383 0.0082
359 PNEUMONIA BACTERIAL 75 0.0082
360 DIVERTICULUM 58 0.0082
361 APPETITE DISORDER 54 0.0081
362 BODY HEIGHT DECREASED 87 0.0081
363 CARDIOMEGALY 100 0.0081
364 UROSEPSIS 75 0.0081
365 APHTHOUS ULCER 63 0.0081
366 SPUTUM DISCOLOURED 77 0.0081
367 AUTOIMMUNE DISORDER 79 0.0081
368 OXYGEN SATURATION DECREASED 455 0.0081
369 GOUT 144 0.0080
370 RESPIRATORY DISTRESS 221 0.0080
371 RETINAL HAEMORRHAGE 57 0.0080
372 OBSTRUCTIVE AIRWAYS DISORDER 89 0.0080
373 BODY TEMPERATURE INCREASED 163 0.0080
374 SPINAL COMPRESSION FRACTURE 66 0.0080
375 NEUTROPHIL COUNT INCREASED 81 0.0079
376 BLOOD MAGNESIUM DECREASED 68 0.0079
377 HYPERCHOLESTEROLAEMIA 76 0.0079
378 RETINAL DETACHMENT 72 0.0078
379 UNEVALUABLE EVENT 592 0.0078
380 CONJUNCTIVITIS 145 0.0078
381 SPINAL DISORDER 74 0.0078
382 TRICUSPID VALVE INCOMPETENCE 62 0.0078
383 MASS 109 0.0078
384 CYANOSIS 122 0.0077
385 EYE DISORDER 255 0.0077
386 CLOSTRIDIUM DIFFICILE INFECTION 169 0.0077
387 CONSTIPATION 1687 0.0077
388 INTERVERTEBRAL DISC PROTRUSION 169 0.0077
389 MUSCULOSKELETAL DISCOMFORT 133 0.0077
390 HAEMATOCRIT DECREASED 153 0.0077
391 FUNGAL INFECTION 257 0.0077
392 RHINITIS 62 0.0077
393 WOUND INFECTION 84 0.0077
394 ULCER 122 0.0077
395 INTRAOCULAR PRESSURE INCREASED 98 0.0077
396 INCONTINENCE 81 0.0077
397 HEREDITARY ANGIOEDEMA 82 0.0076
398 SENSITIVE SKIN 56 0.0076
399 HYPOALBUMINAEMIA 59 0.0076
400 PULMONARY MASS 113 0.0076
401 BACTERAEMIA 90 0.0076
402 ASPIRATION 83 0.0076
403 DIVERTICULITIS 209 0.0075
404 CONTUSION 726 0.0075
405 SEPSIS 838 0.0075
406 OEDEMA 407 0.0075
407 MIGRAINE 716 0.0075
408 BURSITIS 91 0.0075
409 HOSPICE CARE 74 0.0075
410 DYSARTHRIA 282 0.0075
411 SKIN ULCER 193 0.0075
412 BURNING SENSATION 523 0.0075
413 OSTEOARTHRITIS 316 0.0074
414 APHONIA 104 0.0074
415 POOR QUALITY SLEEP 160 0.0074
416 NEPHROLITHIASIS 340 0.0074
417 JOINT INJURY 158 0.0074
418 NEPHROPATHY 69 0.0074
419 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 525 0.0074
420 PELVIC FRACTURE 57 0.0073
421 THERAPY NON-RESPONDER 329 0.0073
422 PNEUMONIA 2366 0.0073
423 INADEQUATE ANALGESIA 62 0.0073
424 INFLUENZA 810 0.0073
425 MOTOR DYSFUNCTION 74 0.0073
426 ENCEPHALOPATHY 178 0.0072
427 RESPIRATORY FAILURE 528 0.0072
428 EMPHYSEMA 73 0.0072
429 HYDRONEPHROSIS 54 0.0072
430 DRUG TOXICITY 98 0.0072
431 BLOOD PRESSURE ABNORMAL 143 0.0072
432 MICTURITION URGENCY 82 0.0072
433 ILEUS 89 0.0072
434 PREMATURE DELIVERY 114 0.0072
435 MITRAL VALVE INCOMPETENCE 81 0.0071
436 PHARYNGEAL SWELLING 70 0.0071
437 BACK PAIN 1660 0.0071
438 LUNG INFILTRATION 63 0.0071
439 LYMPHOCYTE COUNT DECREASED 126 0.0071
440 PARALYSIS 102 0.0071
441 PRODUCT ADMINISTRATION ERROR 144 0.0071
442 ACCIDENT 85 0.0071
443 HERPES ZOSTER 408 0.0071
444 PLEURAL EFFUSION 431 0.0071
445 LEUKOCYTOSIS 128 0.0071
446 TOOTHACHE 128 0.0071
447 DELIRIUM 245 0.0071
448 PULMONARY CONGESTION 93 0.0070
449 BLOOD UREA INCREASED 118 0.0070
450 BALANCE DISORDER 608 0.0070
451 DIZZINESS POSTURAL 68 0.0070
452 ASCITES 206 0.0070
453 PAIN IN JAW 198 0.0070
454 VISUAL ACUITY REDUCED 232 0.0070
455 SEROTONIN SYNDROME 134 0.0070
456 PULMONARY OEDEMA 311 0.0069
457 DISABILITY 137 0.0069
458 PRODUCT DOSE OMISSION ISSUE 2036 0.0069
459 JOINT DISLOCATION 73 0.0069
460 NASOPHARYNGITIS 1270 0.0069
461 BLOOD PRESSURE DECREASED 456 0.0069
462 CHILLS 804 0.0069
463 PAIN 4191 0.0068
464 ANKLE FRACTURE 105 0.0068
465 DENTAL CARIES 75 0.0068
466 BLISTER 380 0.0068
467 GASTROOESOPHAGEAL REFLUX DISEASE 544 0.0068
468 BLOOD IRON DECREASED 80 0.0067
469 SHOCK 155 0.0067
470 HEAD INJURY 213 0.0067
471 FALL 2239 0.0067
472 GROIN PAIN 59 0.0067
473 ACUTE KIDNEY INJURY 1027 0.0067
474 PYELONEPHRITIS 58 0.0067
475 ELECTROLYTE IMBALANCE 77 0.0066
476 IRRITABLE BOWEL SYNDROME 142 0.0066
477 RENAL FAILURE ACUTE 281 0.0066
478 SEIZURE 762 0.0066
479 NODULE 86 0.0066
480 BLOOD POTASSIUM DECREASED 198 0.0066
481 BRAIN INJURY 66 0.0066
482 SPINAL OPERATION 81 0.0066
483 SWELLING 615 0.0066
484 QUALITY OF LIFE DECREASED 88 0.0066
485 INABILITY TO AFFORD MEDICATION 65 0.0065
486 OSTEOPOROSIS 269 0.0065
487 OROPHARYNGEAL PAIN 605 0.0065
488 EAR DISCOMFORT 67 0.0065
489 INFECTION 942 0.0065
490 CARDIO-RESPIRATORY ARREST 272 0.0065
491 EJECTION FRACTION DECREASED 101 0.0065
492 DEVICE RELATED INFECTION 100 0.0065
493 SPINAL FRACTURE 130 0.0065
494 JOINT RANGE OF MOTION DECREASED 87 0.0065
495 PULMONARY HYPERTENSION 135 0.0065
496 CYTOKINE RELEASE SYNDROME 130 0.0065
497 DYSPNOEA EXERTIONAL 244 0.0065
498 HYPOKALAEMIA 299 0.0065
499 BACK DISORDER 105 0.0065
500 RESPIRATORY ARREST 178 0.0065
501 ELECTROCARDIOGRAM QT PROLONGED 232 0.0064
502 CYST 80 0.0064
503 OROPHARYNGEAL DISCOMFORT 58 0.0064
504 ATAXIA 76 0.0064
505 APPLICATION SITE PRURITUS 145 0.0064
506 MUSCLE TIGHTNESS 103 0.0064
507 TINNITUS 291 0.0063
508 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 116 0.0063
509 METABOLIC ACIDOSIS 202 0.0063
510 RHINORRHOEA 408 0.0063
511 LETHARGY 363 0.0063
512 LYMPHADENOPATHY 223 0.0063
513 MUSCLE TWITCHING 145 0.0063
514 PYREXIA 2165 0.0063
515 BONE DISORDER 114 0.0062
516 APPLICATION SITE RASH 86 0.0062
517 HAEMATOCHEZIA 345 0.0062
518 SNEEZING 140 0.0062
519 WOUND 174 0.0062
520 OESOPHAGITIS 68 0.0062
521 LOWER RESPIRATORY TRACT INFECTION 283 0.0062
522 ATRIAL FIBRILLATION 605 0.0062
523 DISCOMFORT 379 0.0062
524 NEUROPATHY PERIPHERAL 588 0.0062
525 HEART RATE DECREASED 217 0.0062
526 ANXIETY 1755 0.0062
527 DRUG ADMINISTERED AT INAPPROPRIATE SITE 65 0.0062
528 ARTERIOSCLEROSIS 58 0.0062
529 BACK INJURY 67 0.0062
530 NASAL CONGESTION 362 0.0062
531 MADAROSIS 71 0.0061
532 ANAEMIA 1166 0.0061
533 ARTHRITIS 480 0.0061
534 RESPIRATORY RATE INCREASED 54 0.0061
535 LOSS OF CONSCIOUSNESS 778 0.0061
536 ACCIDENTAL OVERDOSE 222 0.0061
537 STOMATITIS 368 0.0061
538 GENERALISED OEDEMA 75 0.0061
539 DISSEMINATED INTRAVASCULAR COAGULATION 85 0.0060
540 IMPAIRED HEALING 198 0.0060
541 WEIGHT DECREASED 1680 0.0060
542 RESPIRATORY DISORDER 180 0.0060
543 WRIST FRACTURE 72 0.0060
544 MOBILITY DECREASED 431 0.0060
545 HYPONATRAEMIA 337 0.0060
546 TOOTH DISORDER 133 0.0060
547 HEADACHE 3748 0.0060
548 TUBULOINTERSTITIAL NEPHRITIS 112 0.0060
549 URINARY RETENTION 199 0.0060
550 HAEMOPTYSIS 166 0.0059
551 BLOOD PRESSURE INCREASED 909 0.0059
552 PRODUCT USE IN UNAPPROVED INDICATION 1472 0.0059
553 HYPERSENSITIVITY 1097 0.0059
554 HEPATOMEGALY 58 0.0059
555 ABSCESS 94 0.0059
556 RESTLESS LEGS SYNDROME 107 0.0059
557 PALLOR 160 0.0059
558 SCRATCH 62 0.0059
559 MUSCLE RIGIDITY 70 0.0058
560 ERYTHEMA 1198 0.0058
561 HYPOMAGNESAEMIA 81 0.0058
562 URINARY INCONTINENCE 172 0.0058
563 DRUG INTERACTION 919 0.0058
564 BLOOD SODIUM DECREASED 109 0.0058
565 RED BLOOD CELL COUNT DECREASED 165 0.0058
566 DEHYDRATION 769 0.0058
567 COUGH 1615 0.0058
568 POST PROCEDURAL HAEMORRHAGE 67 0.0057
569 RENAL PAIN 61 0.0057
570 HYPOAESTHESIA 861 0.0057
571 DYSPEPSIA 565 0.0057
572 BLINDNESS 234 0.0057
573 LACERATION 54 0.0057
574 UPPER LIMB FRACTURE 114 0.0057
575 PREMATURE BABY 172 0.0057
576 DRY MOUTH 463 0.0057
577 PULMONARY THROMBOSIS 62 0.0057
578 FOOT DEFORMITY 63 0.0057
579 SWOLLEN TONGUE 177 0.0057
580 COLITIS ULCERATIVE 253 0.0057
581 SPEECH DISORDER 296 0.0056
582 ABDOMINAL DISTENSION 589 0.0056
583 COAGULOPATHY 94 0.0056
584 HERNIA 109 0.0056
585 SKIN DISCOLOURATION 259 0.0056
586 HAEMATOMA 146 0.0056
587 HYPERTENSION 1192 0.0056
588 LIMB DISCOMFORT 174 0.0056
589 EMOTIONAL DISTRESS 679 0.0056
590 HEMIPARESIS 95 0.0056
591 INTENTIONAL PRODUCT USE ISSUE 490 0.0056
592 ABDOMINAL PAIN 1299 0.0056
593 INTESTINAL OBSTRUCTION 210 0.0056
594 DYSURIA 205 0.0056
595 DYSPHAGIA 528 0.0056
596 HYPERKALAEMIA 195 0.0056
597 HYPOTHYROIDISM 177 0.0055
598 WHEEZING 328 0.0055
599 BLOOD URINE PRESENT 105 0.0055
600 HEART RATE INCREASED 545 0.0055
601 MUCOSAL INFLAMMATION 144 0.0055
602 TENDONITIS 85 0.0055
603 SKIN DISORDER 183 0.0055
604 SKIN REACTION 77 0.0055
605 PRODUCT USE ISSUE 1027 0.0055
606 MYOCARDIAL ISCHAEMIA 62 0.0054
607 VERTIGO 329 0.0054
608 MUSCULAR WEAKNESS 612 0.0054
609 BASAL CELL CARCINOMA 84 0.0054
610 SEPTIC SHOCK 234 0.0054
611 COMA 256 0.0054
612 TOOTH FRACTURE 59 0.0053
613 HALLUCINATION, VISUAL 113 0.0053
614 COLD SWEAT 94 0.0053
615 ROAD TRAFFIC ACCIDENT 223 0.0053
616 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 156 0.0053
617 TASTE DISORDER 108 0.0053
618 HYPOTONIA 53 0.0053
619 LOWER LIMB FRACTURE 102 0.0053
620 GASTROINTESTINAL DISORDER 475 0.0053
621 APHASIA 160 0.0053
622 CARDIOMYOPATHY 78 0.0053
623 GASTROINTESTINAL PAIN 58 0.0053
624 WHITE BLOOD CELL COUNT INCREASED 202 0.0053
625 EATING DISORDER 112 0.0053
626 PERIPHERAL SWELLING 810 0.0053
627 HEAD DISCOMFORT 93 0.0052
628 CONFUSIONAL STATE 848 0.0052
629 CHEST PAIN 969 0.0052
630 BLOOD PRESSURE SYSTOLIC INCREASED 102 0.0052
631 INFLUENZA LIKE ILLNESS 430 0.0052
632 HAIR COLOUR CHANGES 65 0.0052
633 HYPERTENSIVE CRISIS 58 0.0052
634 RENAL IMPAIRMENT 438 0.0052
635 BLOOD TEST ABNORMAL 73 0.0052
636 THROMBOSIS 418 0.0052
637 CHROMATURIA 117 0.0052
638 VISUAL IMPAIRMENT 639 0.0052
639 EXPOSURE DURING PREGNANCY 320 0.0051
640 PRESYNCOPE 125 0.0051
641 TOXIC EPIDERMAL NECROLYSIS 78 0.0051
642 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1040 0.0051
643 LIVER FUNCTION TEST INCREASED 110 0.0051
644 BLOOD POTASSIUM INCREASED 83 0.0051
645 SECRETION DISCHARGE 64 0.0051
646 RESTLESSNESS 187 0.0051
647 BLINDNESS UNILATERAL 72 0.0051
648 EYE HAEMORRHAGE 68 0.0051
649 DYSPHONIA 298 0.0051
650 SLEEP DISORDER 359 0.0051
651 PHOTOSENSITIVITY REACTION 84 0.0051
652 EPISTAXIS 380 0.0051
653 SOMNOLENCE 1021 0.0051
654 CHEST DISCOMFORT 519 0.0051
655 PARAESTHESIA 797 0.0051
656 FEELING COLD 141 0.0051
657 TOOTH EXTRACTION 63 0.0051
658 OEDEMA PERIPHERAL 617 0.0051
659 NAUSEA 3997 0.0050
660 FATIGUE 3923 0.0050
661 TREMOR 834 0.0050
662 PAIN IN EXTREMITY 1478 0.0050
663 MUSCULOSKELETAL PAIN 262 0.0050
664 DYSSTASIA 146 0.0050
665 BLOOD PRESSURE FLUCTUATION 120 0.0050
666 BLOOD CHOLESTEROL INCREASED 233 0.0050
667 MOUTH ULCERATION 105 0.0050
668 GASTRITIS 131 0.0050
669 SYNCOPE 494 0.0049
670 ASTHMA 558 0.0049
671 MUSCLE SPASMS 905 0.0049
672 MENTAL DISORDER 214 0.0049
673 DYSPNOEA 2783 0.0049
674 VOMITING 2307 0.0049
675 NERVOUS SYSTEM DISORDER 153 0.0049
676 RETCHING 104 0.0049
677 FLUID RETENTION 248 0.0049
678 NEOPLASM 56 0.0049
679 HEART RATE IRREGULAR 110 0.0049
680 AGITATION 357 0.0049
681 SKIN LESION 133 0.0048
682 DYSKINESIA 197 0.0048
683 ANGIOEDEMA 214 0.0048
684 BLOOD ALKALINE PHOSPHATASE INCREASED 120 0.0048
685 COMPLICATION ASSOCIATED WITH DEVICE 70 0.0048
686 DISORIENTATION 191 0.0048
687 HYPOPHAGIA 123 0.0048
688 PERIPHERAL COLDNESS 66 0.0048
689 ACUTE RESPIRATORY DISTRESS SYNDROME 85 0.0048
690 MUSCULOSKELETAL STIFFNESS 421 0.0048
691 CHOLECYSTITIS 57 0.0048
692 NEEDLE ISSUE 139 0.0048
693 ARRHYTHMIA 226 0.0048
694 SARS-COV-2 TEST POSITIVE 63 0.0048
695 FULL BLOOD COUNT DECREASED 96 0.0048
696 ASPARTATE AMINOTRANSFERASE INCREASED 253 0.0048
697 DEVICE OCCLUSION 67 0.0048
698 CHOLELITHIASIS 156 0.0048
699 THYROID DISORDER 73 0.0047
700 DERMATITIS 99 0.0047
701 HEPATIC STEATOSIS 88 0.0047
702 NIGHT SWEATS 152 0.0047
703 HYPERSOMNIA 135 0.0047
704 IMMUNE SYSTEM DISORDER 62 0.0047
705 TENDON RUPTURE 58 0.0047
706 NOCTURIA 57 0.0047
707 HIP FRACTURE 151 0.0047
708 DERMATITIS ALLERGIC 59 0.0047
709 FACE OEDEMA 79 0.0047
710 DECREASED APPETITE 1088 0.0047
711 TRANSIENT ISCHAEMIC ATTACK 158 0.0047
712 IMPAIRED DRIVING ABILITY 53 0.0047
713 PULMONARY EMBOLISM 443 0.0047
714 PRODUCT DOSE OMISSION IN ERROR 132 0.0047
715 THROAT TIGHTNESS 126 0.0047
716 THROAT IRRITATION 209 0.0047
717 MUSCLE ATROPHY 59 0.0047
718 HAEMOGLOBIN DECREASED 477 0.0046
719 GAIT DISTURBANCE 889 0.0046
720 FEEDING DISORDER 94 0.0046
721 LUNG DISORDER 227 0.0046
722 GAIT INABILITY 154 0.0046
723 DIZZINESS 2296 0.0046
724 PERICARDIAL EFFUSION 106 0.0046
725 POLLAKIURIA 191 0.0046
726 URTICARIA 767 0.0046
727 ACUTE MYOCARDIAL INFARCTION 135 0.0046
728 METASTASES TO CENTRAL NERVOUS SYSTEM 59 0.0046
729 ALTERED STATE OF CONSCIOUSNESS 99 0.0046
730 DRUG INTOLERANCE 440 0.0046
731 GALLBLADDER DISORDER 81 0.0045
732 MATERNAL EXPOSURE DURING PREGNANCY 402 0.0045
733 SKIN CANCER 97 0.0045
734 DEEP VEIN THROMBOSIS 292 0.0045
735 BEDRIDDEN 59 0.0045
736 HYPOKINESIA 65 0.0045
737 ASTHENIA 1682 0.0045
738 SURGERY 262 0.0045
739 HAEMATURIA 153 0.0045
740 MALAISE 1957 0.0045
741 PRODUCT AVAILABILITY ISSUE 101 0.0044
742 DYSTONIA 86 0.0044
743 BLOOD TRIGLYCERIDES INCREASED 78 0.0044
744 MENTAL IMPAIRMENT 107 0.0044
745 PANCYTOPENIA 244 0.0044
746 UPPER GASTROINTESTINAL HAEMORRHAGE 73 0.0043
747 HAIR TEXTURE ABNORMAL 58 0.0043
748 PULMONARY FIBROSIS 83 0.0043
749 C-REACTIVE PROTEIN INCREASED 157 0.0043
750 GASTRIC ULCER 82 0.0043
751 LUNG INFECTION 67 0.0043
752 ARTHRALGIA 1793 0.0043
753 JOINT STIFFNESS 112 0.0043
754 PALPITATIONS 500 0.0043
755 OBESITY 68 0.0043
756 OFF LABEL USE 3736 0.0043
757 ARTHROPATHY 237 0.0043
758 GINGIVAL BLEEDING 58 0.0042
759 SENSORY DISTURBANCE 68 0.0042
760 DEPRESSION 962 0.0042
761 AMNESIA 275 0.0042
762 POISONING 53 0.0042
763 DIARRHOEA 2723 0.0042
764 MEDICATION ERROR 234 0.0042
765 INTENTIONAL PRODUCT MISUSE 368 0.0042
766 BONE PAIN 246 0.0042
767 ACTIVITIES OF DAILY LIVING IMPAIRED 83 0.0042
768 THINKING ABNORMAL 78 0.0042
769 RASH 1816 0.0042
770 INFLAMMATION 214 0.0041
771 RASH MACULO-PAPULAR 92 0.0041
772 LOCAL SWELLING 72 0.0041
773 DIABETES MELLITUS 314 0.0041
774 PARANOIA 71 0.0041
775 DEMENTIA 115 0.0041
776 DRUG ABUSE 342 0.0041
777 ALANINE AMINOTRANSFERASE INCREASED 252 0.0041
778 INTENTIONAL DOSE OMISSION 117 0.0041
779 HALLUCINATION 309 0.0041
780 THERAPY INTERRUPTED 293 0.0041
781 HYPERHIDROSIS 525 0.0041
782 BLOOD BILIRUBIN INCREASED 110 0.0041
783 IMPAIRED WORK ABILITY 87 0.0041
784 CORONARY ARTERY DISEASE 123 0.0041
785 RASH PAPULAR 91 0.0041
786 PRODUCT PRESCRIBING ISSUE 88 0.0040
787 THERAPEUTIC RESPONSE UNEXPECTED 181 0.0040
788 RASH MACULAR 141 0.0040
789 RASH PRURITIC 218 0.0040
790 BLOOD CREATININE INCREASED 262 0.0040
791 FAECES DISCOLOURED 87 0.0040
792 PULMONARY ARTERIAL HYPERTENSION 58 0.0040
793 PLATELET COUNT DECREASED 425 0.0040
794 INSOMNIA 1060 0.0040
795 MYALGIA 674 0.0040
796 HYPOCALCAEMIA 75 0.0040
797 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 190 0.0040
798 DEAFNESS 103 0.0039
799 PRURITUS 1511 0.0039
800 PERICARDITIS 66 0.0039
801 RENAL DISORDER 182 0.0039
802 METASTASES TO BONE 64 0.0039
803 PNEUMONITIS 106 0.0039
804 NEUTROPHIL COUNT DECREASED 158 0.0039
805 COORDINATION ABNORMAL 54 0.0039
806 STEVENS-JOHNSON SYNDROME 86 0.0039
807 HYPERTHYROIDISM 56 0.0039
808 NERVOUSNESS 202 0.0039
809 THIRST 69 0.0039
810 FLATULENCE 219 0.0039
811 HAEMORRHAGE 400 0.0038
812 FEELING HOT 234 0.0038
813 ABDOMINAL DISCOMFORT 637 0.0038
814 FLUSHING 386 0.0038
815 PREGNANCY 76 0.0038
816 FLUID OVERLOAD 55 0.0038
817 PANIC ATTACK 137 0.0038
818 JOINT SWELLING 453 0.0037
819 CARDIAC FAILURE CONGESTIVE 301 0.0037
820 DISTURBANCE IN ATTENTION 202 0.0037
821 PELVIC PAIN 68 0.0037
822 MOVEMENT DISORDER 120 0.0037
823 BONE DENSITY DECREASED 117 0.0037
824 MEMORY IMPAIRMENT 513 0.0037
825 THROMBOCYTOPENIA 415 0.0037
826 WEIGHT INCREASED 830 0.0037
827 IMMUNODEFICIENCY 55 0.0037
828 AGEUSIA 92 0.0037
829 FEELING ABNORMAL 883 0.0037
830 RASH ERYTHEMATOUS 176 0.0037
831 HEPATIC CIRRHOSIS 69 0.0037
832 WHITE BLOOD CELL COUNT DECREASED 398 0.0037
833 TOOTH LOSS 76 0.0037
834 GENERAL PHYSICAL HEALTH DETERIORATION 418 0.0036
835 PRODUCT PREPARATION ERROR 74 0.0036
836 ANGINA PECTORIS 103 0.0036
837 HAEMATEMESIS 91 0.0036
838 CONVULSION 205 0.0036
839 DYSGEUSIA 266 0.0036
840 GLOSSODYNIA 80 0.0036
841 ABDOMINAL PAIN UPPER 733 0.0036
842 CARDIAC DISORDER 332 0.0035
843 CEREBRAL HAEMORRHAGE 126 0.0035
844 HOT FLUSH 264 0.0035
845 CEREBROVASCULAR ACCIDENT 593 0.0035
846 OVERDOSE 754 0.0035
847 PSYCHOMOTOR HYPERACTIVITY 58 0.0035
848 DELUSION 54 0.0035
849 TREATMENT FAILURE 287 0.0035
850 HIP ARTHROPLASTY 53 0.0035
851 OSTEONECROSIS OF JAW 85 0.0034
852 PLASMA CELL MYELOMA 134 0.0034
853 ADVERSE DRUG REACTION 307 0.0034
854 GASTROINTESTINAL HAEMORRHAGE 285 0.0034
855 HYPOACUSIS 145 0.0034
856 ABDOMINAL PAIN LOWER 84 0.0033
857 CARDIAC FAILURE 263 0.0033
858 RHEUMATOID ARTHRITIS 369 0.0032
859 HYPERGLYCAEMIA 118 0.0032
860 LIVER DISORDER 143 0.0032
861 SKIN FISSURES 63 0.0032
862 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 75 0.0032
863 MIDDLE INSOMNIA 60 0.0032
864 PROTEINURIA 61 0.0032
865 OSTEONECROSIS 105 0.0032
866 THERAPEUTIC PRODUCT EFFECT DECREASED 143 0.0032
867 INTERNATIONAL NORMALISED RATIO INCREASED 91 0.0032
868 INCORRECT ROUTE OF DRUG ADMINISTRATION 114 0.0032
869 NEUTROPENIA 433 0.0032
870 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 54 0.0032
871 SUICIDAL IDEATION 288 0.0031
872 ACCIDENTAL EXPOSURE TO PRODUCT 323 0.0031
873 INJECTION SITE MASS 115 0.0031
874 CRYING 113 0.0031
875 MUSCULOSKELETAL DISORDER 59 0.0031
876 SYSTEMIC LUPUS ERYTHEMATOSUS 110 0.0031
877 ALOPECIA 606 0.0031
878 HEPATIC FAILURE 93 0.0031
879 EOSINOPHILIA 54 0.0031
880 DISEASE PROGRESSION 361 0.0030
881 KNEE ARTHROPLASTY 64 0.0030
882 SKIN IRRITATION 139 0.0030
883 GASTRIC DISORDER 104 0.0030
884 PRODUCT PHYSICAL ISSUE 61 0.0030
885 FEELING JITTERY 57 0.0030
886 HOSPITALISATION 459 0.0030
887 SKIN EXFOLIATION 252 0.0030
888 EMOTIONAL DISORDER 92 0.0030
889 CHOKING 58 0.0030
890 THERAPEUTIC RESPONSE DECREASED 180 0.0030
891 PRURITUS GENERALISED 64 0.0030
892 ECZEMA 154 0.0029
893 DRUG EFFECT INCOMPLETE 106 0.0029
894 EPILEPSY 89 0.0029
895 TYPE 2 DIABETES MELLITUS 97 0.0029
896 TRANSAMINASES INCREASED 64 0.0029
897 CEREBRAL INFARCTION 70 0.0029
898 NIGHTMARE 99 0.0029
899 BLOOD GLUCOSE DECREASED 137 0.0029
900 DRY SKIN 380 0.0028
901 DEPRESSED MOOD 150 0.0028
902 WITHDRAWAL SYNDROME 119 0.0028
903 NEOPLASM PROGRESSION 98 0.0028
904 MELAENA 62 0.0028
905 INJECTION SITE SWELLING 215 0.0028
906 HYPOGLYCAEMIA 136 0.0028
907 INJECTION SITE PRURITUS 186 0.0028
908 INJECTION SITE PAIN 849 0.0028
909 MALIGNANT NEOPLASM PROGRESSION 282 0.0028
910 LACTIC ACIDOSIS 89 0.0027
911 PRESCRIBED OVERDOSE 53 0.0027
912 PSORIATIC ARTHROPATHY 111 0.0027
913 FOETAL EXPOSURE DURING PREGNANCY 222 0.0027
914 NEOPLASM MALIGNANT 181 0.0027
915 RASH GENERALISED 70 0.0027
916 WRONG TECHNIQUE IN DRUG USAGE PROCESS 98 0.0027
917 IRRITABILITY 162 0.0027
918 MULTIPLE SCLEROSIS 128 0.0027
919 LABORATORY TEST ABNORMAL 78 0.0026
920 BLOOD CREATINE PHOSPHOKINASE INCREASED 76 0.0026
921 HEPATIC ENZYME INCREASED 179 0.0026
922 HEPATIC FUNCTION ABNORMAL 97 0.0026
923 TREATMENT NONCOMPLIANCE 141 0.0026
924 PRODUCT DOSE OMISSION 166 0.0025
925 ILL-DEFINED DISORDER 154 0.0025
926 INJECTION SITE BRUISING 202 0.0025
927 DEVICE DISLOCATION 110 0.0025
928 PSYCHOTIC DISORDER 74 0.0025
929 INJECTION SITE ERYTHEMA 310 0.0025
930 LEUKOPENIA 124 0.0025
931 INTERSTITIAL LUNG DISEASE 120 0.0025
932 AGGRESSION 123 0.0025
933 INTENTIONAL OVERDOSE 157 0.0024
934 RHABDOMYOLYSIS 101 0.0024
935 THERAPY CESSATION 123 0.0024
936 PANCREATITIS 126 0.0024
937 MOOD ALTERED 65 0.0024
938 THERAPEUTIC RESPONSE SHORTENED 79 0.0024
939 INCORRECT DOSE ADMINISTERED 530 0.0023
940 DEATH 1994 0.0023
941 CONTRAINDICATED PRODUCT ADMINISTERED 70 0.0023
942 HEPATITIS 59 0.0023
943 DRUG EFFECT DECREASED 124 0.0023
944 GLYCOSYLATED HAEMOGLOBIN INCREASED 58 0.0023
945 EXTRAPYRAMIDAL DISORDER 57 0.0023
946 ADVERSE EVENT 211 0.0023
947 JAUNDICE 60 0.0022
948 PRODUCT SUBSTITUTION ISSUE 127 0.0022
949 FEMUR FRACTURE 68 0.0022
950 PAIN OF SKIN 59 0.0022
951 ANGER 74 0.0022
952 DRUG-INDUCED LIVER INJURY 68 0.0022
953 INJECTION SITE REACTION 149 0.0022
954 EXPOSURE VIA SKIN CONTACT 56 0.0022
955 LIVER INJURY 53 0.0022
956 CARDIOVASCULAR DISORDER 54 0.0021
957 ABNORMAL BEHAVIOUR 84 0.0021
958 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 71 0.0021
959 DEVICE ISSUE 188 0.0021
960 MYOCARDIAL INFARCTION 363 0.0021
961 BLOOD GLUCOSE INCREASED 392 0.0021
962 LIVER FUNCTION TEST ABNORMAL 59 0.0020
963 ABNORMAL DREAMS 54 0.0020
964 NO ADVERSE EVENT 350 0.0019
965 PRODUCT STORAGE ERROR 166 0.0019
966 VAGINAL HAEMORRHAGE 82 0.0019
967 DEVICE LEAKAGE 78 0.0018
968 INJECTION SITE RASH 55 0.0018
969 INJECTION SITE HAEMORRHAGE 142 0.0018
970 MULTIPLE SCLEROSIS RELAPSE 121 0.0018
971 MOOD SWINGS 56 0.0018
972 DRUG EXPOSURE DURING PREGNANCY 58 0.0017
973 DISEASE RECURRENCE 81 0.0017
974 SUICIDE ATTEMPT 103 0.0017
975 PSORIASIS 218 0.0017
976 COMPLETED SUICIDE 135 0.0016
977 SKIN BURNING SENSATION 114 0.0016
978 EXTRA DOSE ADMINISTERED 64 0.0016
979 DEVICE MALFUNCTION 110 0.0016
980 ACNE 115 0.0015
981 DRUG DOSE OMISSION 245 0.0015
982 DRUG WITHDRAWAL SYNDROME 130 0.0015
983 DEVICE DIFFICULT TO USE 98 0.0015
984 UNDERDOSE 108 0.0015
985 DEVICE BREAKAGE 58 0.0014
986 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 62 0.0013
987 LUNG NEOPLASM MALIGNANT 54 0.0013
988 DERMATITIS ATOPIC 66 0.0013
989 DRUG DEPENDENCE 190 0.0012
990 BREAST CANCER 104 0.0011